The US Food and Drug Administration has approved Vyloy (zolbetuximab-clzb), a claudin 18.2 (CLDN18.2)-directed cytolytic ...

As the European Parliament prepares for the confirmation hearings of the new Commissioners, the Open Trade Coalition is ...

A century later, that sentiment is as pertinent as ever. Artificial Intelligence (AI) is being incorporated into a myriad of ...

After a couple of negative decisions, the US Food and Drug Administration (FDA) has approved Vyalev (foscarbidopa and ...

Shanghai-based biopharma LaNova Medicines has raised 3 billion yuan ($41 million) in a series C round led by China ...

OmniaBio, a subsidiary of Canada's Centre for Commercialization of Regenerative Medicine, has opened a 120,000-square-foot ...

British AI drug discovery firm BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. His ...

Taiwan-based REGiMMUNE, a biopharma creating immunotherapies through the power of regulatory T cells (Tregs), and ...

The US Food and Drug Administration (FDA) has updated the US label for French pharma major Sanofi’s Flublok (Influenza ...

Gan & Lee Pharmaceuticals (SHE: 603087) reported positive Phase II trial results for its diabetes drugs GZR18, GZR4, and ...

Texas, USA-based Lexicon Pharmaceuticals announced that Viatris has obtained an exclusive license from Lexicon to ...

A new NIH clinical trial shows the Jynneos (MVA-BN) vaccine is safe for adolescents and produces an antibody response similar ...